Literature DB >> 6196642

All metacyclic variable antigen types of Trypanosoma congolense identified using monoclonal antibodies.

J S Crowe, J D Barry, A G Luckins, C A Ross, K Vickerman.   

Abstract

Vaccination against the tsetse-borne trypanosomiases has proved impossible because of the trypanosome's ability to generate a seemingly inexhaustible number of variable antigen types in the blood or tissues of the host. Each variable antigen is a glycoprotein which forms a surface coat on the trypanosome and each glycoprotein is the product of a single gene. The full repertoire of such antigens has not been identified for any trypanosome serodeme (genotype) as yet, but the number of genes coding for variable antigen glycoproteins is estimated to be between 100 and 1,000. We have previously postulated that for Trypanosoma brucei the antigen repertoire of the infective metacyclic stage trypanosomes inoculated by the tsetse fly may be considerably smaller than that expressed in the mammalian host. If this is so then protection against infection by the vector becomes an easier proposition, but the actual scale of the metacyclic repertoire is also unknown. We present here evidence that the metacyclic repertoire of a stock of T. congolense, the most important of the pathogenic cattle trypanosomes, is limited to 12 variable antigen types.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6196642     DOI: 10.1038/306389a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  19 in total

Review 1.  Molecular biology of trypanosome antigenic variation.

Authors:  J E Donelson; A C Rice-Ficht
Journal:  Microbiol Rev       Date:  1985-06

2.  Trypanosomosis research at the Centre for Tropical Veterinary Medicine (CTVM) 1970 to 1995.

Authors:  R Boid; A G Hunter; T W Jones; C A Ross; D Sutherland; A G Luckins
Journal:  Trop Anim Health Prod       Date:  1996-02       Impact factor: 1.559

3.  Duplicative activation mechanisms of two trypanosome telomeric VSG genes with structurally simple 5' flanks.

Authors:  K R Matthews; P G Shiels; S V Graham; C Cowan; J D Barry
Journal:  Nucleic Acids Res       Date:  1990-12-25       Impact factor: 16.971

4.  Activity of a trypanosome metacyclic variant surface glycoprotein gene promoter is dependent upon life cycle stage and chromosomal context.

Authors:  S V Graham; B Wymer; J D Barry
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

5.  Metacyclic variant surface glycoprotein genes of Trypanosoma brucei subsp. rhodesiense are activated in situ, and their expression is transcriptionally regulated.

Authors:  M J Lenardo; K M Esser; A M Moon; L H Van der Ploeg; J E Donelson
Journal:  Mol Cell Biol       Date:  1986-06       Impact factor: 4.272

6.  A strand bias occurs in point mutations associated with variant surface glycoprotein gene conversion in Trypanosoma rhodesiense.

Authors:  Y Lu; C M Alarcon; T Hall; L V Reddy; J E Donelson
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

7.  Expression of antigenic regions of a trypanosome variable surface glycoprotein in E. coli using Bal-31 nuclease digestion.

Authors:  M J Lenardo; S T Brentano; J E Donelson
Journal:  Nucleic Acids Res       Date:  1984-06-11       Impact factor: 16.971

8.  Characteristics of trypanosome variant antigen genes active in the tsetse fly.

Authors:  A W Cornelissen; G A Bakkeren; J D Barry; P A Michels; P Borst
Journal:  Nucleic Acids Res       Date:  1985-07-11       Impact factor: 16.971

9.  Characterization of the genes specifying two metacyclic variable antigen types in Trypanosoma brucei rhodesiense.

Authors:  M J Lenardo; A C Rice-Ficht; G Kelly; K M Esser; J E Donelson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

10.  Susceptibility of different breeds of goats in Kenya to experimental infection with Trypanosoma congolense.

Authors:  D D Whitelaw; G P Kaaya; J E Moulton; S K Moloo; M Murray
Journal:  Trop Anim Health Prod       Date:  1985-08       Impact factor: 1.559

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.